https://www.globenewswire.com/news-release/2026/07/09/3325085/0/en/serina-therapeutics-announces-completion-of-sentinel-dosing-in-cohort-1-of-phase-1b-registrational-trial-of-ser-252-for-advanced-parkinson-s-disease.html